Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 1,231 | 1,635 | 16 | 0 | 11,378 |
| Gross Profit | 1,231 | 1,635 | 16 | N/A | 11,378 |
| Operating Expenses | 10,391 | 20,292 | 16,256 | 18,040 | 16,112 |
| Operating Income | -9,160 | -18,658 | -16,240 | -18,040 | -4,734 |
| Other Income | -5,377 | 919 | 2,281 | -109 | -1,920 |
| Pre-tax Income | -14,537 | -17,739 | -13,960 | -18,149 | -6,655 |
| Income Tax | -1,131 | -178 | -183 | -267 | -362 |
| Net Income Continuous | -13,407 | -17,561 | -13,777 | -17,882 | -6,293 |
| Net Income | $-13,407 | $-17,561 | $-13,777 | $-17,882 | $-6,293 |
| EPS Basic Total Ops | -12.25 | -33.31 | -37.80 | -67.50 | -26.50 |
| EPS Basic Continuous Ops | -12.23 | -33.30 | -37.38 | -67.50 | -26.74 |
| EPS Diluted Total Ops | -12.25 | -33.31 | -37.80 | -67.50 | -26.50 |
| EPS Diluted Continuous Ops | -12.23 | -33.30 | -37.38 | -67.50 | -26.74 |
| EPS Diluted Before Non-Recurring Items | -12.24 | -33.30 | -38.00 | -67.50 | -26.50 |
| EBITDA(a) | $-8,555 | $-17,432 | $-14,982 | $-16,623 | $-3,789 |